LORMA COLLEGES CON TEMPLATE

DRUG STUDY
RELATED LEARNING EXPERIENCE

SAMPAGA, JANINE SHAIRA A.

STUDENT NAME: ROTATION: 8th AREA: NICU
YR LEVEL AND SEC: BSN II- Orlando DATES :July 15, 2021 CLINICAL INSTRUCTOR: Ma’am Sharon Catli,
MAN

DRUG NAME CLASSIFICATION MECHANISM OF ACTION INDICATION CONTRAINDICATION SIDE EFFECTS NURSING RESPONSIBILITIES

GENERIC NAME: PHARMACOLOGIC: Acts directly on both Epinephrine is the Contraindicated Restlessness, Monitor BP, pulse,
Adrenergic alpha and beta primary drug with allergy or tremor, weakness, respirations, and urinary
Epinephrine hypersensitivity to dizziness, output and observe
receptors; the most administered during
Therapeutic: potent activator of alpha neonatal resuscitation epinephrine or palpitations, pallor, patient closely following
bronchodilator, receptors. Strengthens where the newborn components of respiratory IV administration.
BRAND NAME: vasopressor, cardiac myocardial contraction; remains bradycardic preparation; difficulties.
Epifren stimulant narrow-angle Epinephrine may widen
increases systolic but with heart rate <60
glaucoma; shock pulse pressure. If
may decrease diastolic bpm after 30 seconds
other than disturbances in cardiac
blood pressure; of what appears to be anaphylactic rhythm occur, withhold
DOSAGE: increases cardiac rate effective ventilation shock; epinephrine and notify
0.2mg and cardiac output. with chest rise, hypovolemia and physician immediately.
followed by 30s of cardiac dilation.
coordinated chest Keep physician informed
ROUTE: compressions. of any changes in intake-
Epinephrine increases output ratio.
Intravenous arterial blood pressure
and coronary Use cardiac monitor with
perfusion during CPR patients receiving
epinephrine IV.
via alpha-1-
adrenoceptor agonist
Observe the patient
closely for adverse
 effects. reactions.

References:https://glowm.com/resources/glowm/cd/pages/drugs/e011.html